Recruiting

HeartBeam ECG

Sponsor:

HeartBeam, Inc.

Code:

NCT07501299

Conditions

Atrial Fibrillation

Atrial Flutter

Bradycardia

Tachycardia

Arrhythmia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Electrocardiogram (ECG)

Study Details

Brief summary:

The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.

Conditions

Atrial Fibrillation

Atrial Flutter

Bradycardia

Tachycardia

Arrhythmia

Study ID

NCT07501299

Start date

Mar 30, 2026

Status verified date

Jul, 2026

Completion date

Dec, 2028

Anticipated

Primary completion date

Dec, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Undergoing ECG as part of standard of care.
2. Able and willing to provide written informed consent.

Exclusion Criteria:

1. Open chest wounds or surgery to the chest or abdomen within 30 days.
2. Inability to complete ECG acquisition with either HeartBeam device or standard 12-L ECG.
3. Unstable condition where registry participation may interfere with care.

Study Design

Enrollment

600 participants

Anticipated

Interventions and Outcome Measures

Interventions

Electrocardiogram (ECG)

The intervention consists of non-invasive ECG recordings obtained using the HeartBeam System. Participants will use the device to capture cardiac electrical activity for assessment of heart rhythm, conduction patterns, and heart rate abnormalities in a clinical setting.

Primary outcome measure

  • Creation of a de-identified ECG dataset for future research and regulatory use [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Locations

Allegheny Health Network

Recruiting

Pittsburgh, Pennsylvania, United States, 15212

Contacts

Principal Investigator:

Joshua Silverstein, MD

More Information

Sponsor

HeartBeam, Inc.

Last update posted

Jul 20, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by HeartBeam, Inc. on 2026-07-20.